2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Sunday, December 13, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Treatment Considerations, Women’s Health, Biological Processes, Pathogenesis, Genomics, Immune Mechanism, Metabolism, Molecular Biology, Multi-Systemic Interactions, Diseases, Bleeding and Clotting, Platelet Disorders, Thrombocytopenias, Thrombotic Disorders, Immunology, Autoimmune Disorders, Autoimmune Hemolytic Anemia, Infectious Diseases, Viral, Research, Fundamental Science, Translational Research, Study Population, Animal Model
PAPER

3069 Obesity-induced platelet mitofusin-1 promotes thrombospondin-1 release and vascular dysfunction

Gowtham Annarapu, PhD, Stefanie Taiclet2, Scott Hahn, MS3, Annika Adesokan4, Deirdre Nolfi-Donegan, MD5, Michael Jurczak6, Adam Straub, PhD7, Sruti Shiva, PhD8
1 Division of Classical Hematology, Department of Medicine,, Pittsburgh, Pennsylvania, United States, Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, Pittsburgh, Pennsylvania, United States
2 Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, Pittsburgh, Pennsylvania, United States
3 Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, Pittsburgh, Pennsylvania, United States
4 Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, Pittsburgh, Pennsylvania, United States
5 Department of Pediatrics, Division of Pediatric Hematology/Oncology, Pittsburgh, Pennsylvania, United States
6 Center for Metabolism and Mitochondrial Medicine (C3M), University of Pittsburgh School of Medicine,, Pittsburgh, Pennsylvania, United States, Department of Medicine, Division of Endocrinology, , University of Pittsburgh School of Medicine,, Pittsburgh, Pennsylvania, United States
7 Department of Pharmacology & Chemical Biology, Pittsburgh, Pennsylvania, United States
8 Center for Metabolism and Mitochondrial Medicine (C3M), University of Pittsburgh School of Medicine,, Pittsburgh, Pennsylvania, United States, Division of Classical Hematology, Department of Medicine,, Pittsburgh, Pennsylvania, United States, Hemophilia Center of Western Pennsylvania, Pittsburgh, Pennsylvania, United States, Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, Pittsburgh, Pennsylvania, United States

Background: Obesity is associated with elevated platelet reactivity, endothelial dysfunction, and vascular injury, yet the platelet-intrinsic mechanisms linking metabolic stress to vascular dysfunction remain incompletely defined. Traditionally, platelets are thought to contribute to obesity-linked vascular dysfunction purely through thrombogenesis.  However, platelets are metabolically active, release vaso-modulatory molecules, and the contribution of these non-thrombotic platelet functions to obesity-induced vasculopathy has not been fully investigated. We previously demonstrated that altered platelet mitochondrial function regulates platelet degranulation. Here, we demonstrate that platelets from obese human subjects have increased mitofusin-1 (MFN1), a small GTP-ase that regulates mitochondrial function. Prior studies reported that obese individuals have elevated plasma thrombospondin 1 (TSP1), a platelet factor that propagates endothelial dysfunction. Based on these findings we hypothesize that obesity-induced platelet MFN1 promotes TSP1 release which drives obesity-associated vascular dysfunction.

Methods: Platelets and plasma from lean (N=6; 3 Males/3 Females; BMI < 25;) and obese human subjects (N=5; 3 Males/2 Females; BMI >30;)   were analyzed to determine whether MFN1 and TSP1 were altered in a human obese population. To determine whether platelet MFN1 causes obesity-induced vascular dysfunction, we utilized a diet-induced obesity murine model and generated a mouse strain which lacks MFN1 in platelets (plt-MFN1KO). PF4-cre control and plt-MFN1KO mice were fed a high-fat diet (HFD; 60 kcal% fat) or low-fat diet (LFD; 10 kcal% fat) for 10 weeks. Endothelial-dependent vascular function was measured by acetylcholine-stimulated vasorelaxation of aortic rings, and vascular injury was assessed by Masson's trichrome staining for collagen deposition in aortic vessels. To investigate the mechanism by which MFN1 regulates TSP1 release under HFD conditions, plasma TSP1 levels were measured by ELISA and key proteins that regulate platelet degranulation machinery (Munc18b and SNAP-23) were evaluated by immunoblotting.

Results:   A preliminary mitochondrial-targeted proteomic screen of platelets from obese and lean human subjects showed that obese subject have increased protein levels of MFN1, and these levels positively correlate with circulating plasma TSP1 levels. In a murine model, control mice fed with HFD showed impaired acetylcholine-stimulated vasorelaxation, indicative of endothelial-dependent vascular dysfunction compared to LFD fed control mice. This effect was significantly attenuated in pltMFN1KO mice fed with HFD. Similarly, HFD-fed control mice showed increased aortic collagen deposition, whereas HFD-fed plt-MFN1KO mice showed significantly reduced fibrotic area, indicating that the loss of platelet MFN1 protects against obesity-induced vascular dysfunction and vascular injury. This attenuation of vascular dysfunction in the plt-MFN1KO mouse was associated with significantly lower levels of plasma TSP1 compared with HFD- control mice. To determine whether MFN1 regulates platelet degranulation to mechanistically modulate TSP1 release, we examined Munc18b and SNAP-23 as key regulators for degranulation. Platelets from plt-MFN1KO mice showed reduced total and phosphorylated Munc18b under both LFD and HFD conditions compared to controls, whereas total and phosphorylated SNAP-23 were not significantly altered.

Conclusions: These data demonstrate that platelet MFN1 is selectively increased by obesity and promotes TSP1 release and contributes to endothelial dysfunction and vascular remodeling. The reduction in Munc18b abundance and phosphorylation in MFN1-deficient platelets identifies a potential mechanism by which platelet MFN1 regulates alpha-granule secretion. Together, these findings define a signaling axis that positions platelet secretory function as the mechanistic link between obesity to vascular injury and suggest that targeting non-thrombotic platelet secretory pathways may mitigate obesity-associated vasculopathy.

Gowtham Annarapu, PhD: No relevant conflicts of interest to declare.